International Center for the Study of Pyschiatry and Psychology
Home arrow Newsletters 2002 - 2006 arrow Winter 2006
Main Menu
Home
About ICSPP
Board of Directors
Mission Statement
Forum
News
Contact Us
Position Papers
Publications
Conferences
Drug Information
Places to Get Help-Links
World Opinion
Research
Newsletters 2002 - 2006
ICSPP Journal
Join ICSPP
Events
Login Form
Welcome, Guest. Please login or register.
Did you miss your activation email?
September 06, 2008, 10:06:13 PM
Username:

Password:

Stay logged in for:

Forgot your password?
Winter 2006 PDF Print E-mail

ICSPP Newsletter

International Center for the Study of Psychiatry and Psychology

New 2006 ICSPP Dues Structure and EHPP

 

            At the end of the 2005 ICSPP Fall conference one of our overseas presenters asked with some passion (and I paraphrase) “Where do we go from here – what do I take back overseas to help others change the direction of our field?” That is a question that has deep relevance not only for each individual but for ICSPP as an organization. We are at a crossroads and must decide where our commitments are to be made with the resources at our command. As we struggle to answer such questions we are confronted with certain realities that often have dollar signs attached to them. One of those realities has to do with our scientific journal “Ethical Human Psychology and Psychiatry (EHPP).”  We have had a series of meetings with our publisher, Springer, concerning the future of EHPP and they have made clear that unless we greatly increase the number of paid subscriptions we run a serious risk of being cancelled. At the time of these discussions (before and during the Fall 2005 conference) Springer was aware that that we had a dues paying membership of over three hundred but less than one hundred subscriptions from members of our own organization. Springer also is aware that they have not made the kind of commitment to EHPP that would greatly boost the number of subscriptions. Our discussions with Springer management were frank, friendly, yet realistic. We agreed to dramatically increase the number of subscriptions within the organization and they have agreed to increase spending on advertising and promotion.

            It is our feeling that EHPP is as vital to the success and future of ICSPP as the yearly conference or any other activity that allows us to achieve the scientific and educational goals that comprise ICSPP’s mission. Many of us are of the belief that it is possible that as goes EHPP so goes ICSPP. EHPP is the only scientific journal that encourages publication of articles critical of mainstream mental health practices and gives a voice to those who would see our field go in other more scientific and humanistic directions. It is listed on every important academic and medical data base world wide with enormous moral, scientific and economic potential for ICSPP’s success.

Therefore the Board of Directors has voted to change the dues structure as follows: As of 2006 dues will be $100.00 dollars instead of the current $50.00 and will automatically include a subscription to Ethical Human Psychology and Psychiatry (EHPP). Of course those who find these dues onerous can continue to follow our existing policy under such circumstances: Pay $50.00 OR whatever you can but be aware that you will not receive EHPP unless you pay the full $100.00. Please pay your dues as soon as possible and begin receiving and enjoying the wonderful EHPP. Now is the time to make your commitment to the health and future of our unique and vitally important organization.

Thank You!!!

Remembering the 2005 ICSPP Conference: An Editorial

            This was my second year as conference co-chair helping to organize the Fall International Conference. Like the first, it was my pleasure to work with Dominick Riccio and the others who contributed so much time and effort in making these conferences the success that so many agree that they were. And like the first, I found my work extremely gratifying and stimulating to my

personal and professional growth as well as exhausting, enervating, and frustrating. Next year’s conference will be held in Washington D.C. and Dominick’s co-chair will be Jake Johnson. I offer Jake my very best wishes for his efforts.

            I found a number of presentations to be exciting and worthwhile and wish to touch on just a few. There were a number of presentations dealing with the use of Psychoanalysis in dealing with severe emotional problems including “schizophrenia.” Burt Karon’s discussion was as usual enlightening, humorous, and wholly enjoyable. I sat enthralled with Dominick Riccio’s impassioned exposition of the analytic techniques necessary for the long term help of psychotic patients. Equally thrilling was Grace Jackson’s presentation based on her new and must read book “Rethinking Psychiatric Drugs.” Grace’s knowledge about the brain and the effect of psychiatric drugs is encyclopedic and most impressive. I found Daniel Dorman’s discussion, based on his book Dante’s Cure, which deals with a seven year analysis of his patient Catherine Penny, totally engrossing and led me to buy, read and assign his book to my students, as well as had me wishing I had the patience and courage to work with severely disturbed individuals as he does. Equally intriguing was Peter Breggin’s plenary session in which he suggested that the rise in “Bipolar Disorder,” psychiatry’s new disease of the week, is largely due to the ever increasing use of SSRI and other “anti-depressant miracle drugs.”

            I was delighted that our conference was a step in forging a relationship with ISPS (International Society for the Psychological Treatments of Schizophrenia). Ann Louise Silver’s presentation dealing with the life and death of Chestnut Lodge was not only illuminating but in a way represented a metaphor for the entire mental health field from the days in which humanistic and dynamic theories were dominant until our present, sadly minimalist time when the human mind and spirit have been reduced to the action of molecules and the imaginative creation of new theory largely replaced with a search for new techniques “that work.” (Dr. Silver is president of ISPS.) I was therefore excited by ISPS member Brian Koehler’s expansive theoretical discussion of the causes of psychosis and greatly look forward to the publication of the book from which his speech was drawn.

            I was impressed with Bill Andrew’s concept of “human givens” and the presentation that included these vital ideas. Bill is from across the pond as was Bob Johnson whose work with supposedly hardened criminals in British prisons is astounding. Bob has accepted our invitation to return next year and present his work as a plenary speaker and I urge all who read this to attend the conference and under no circumstances miss Bob’s presentation. Jonathan Leo and Jeffrey Lacasse did a superb job in a workshop discussing the disconnect between the scientific evidence for serotonin deficiency and the content of Big Pharma’s public advertising campaigns.

            Finally, allow me thank all of our presenters and express my gratitude for their efforts as well as my sorrow that I could not attend each and every session and workshop.  

            This brings me to my critique of the conference and the single presentation that I thought to be both the most important and under attended: Louis Wynne’s erudite exposition entitled “Dr. Szasz’ Gauntlet.” The title of this year’s conference was “Schizophrenia and Bipolar Disorders: Scientific Facts or Scientific Delusions.” Except for Dr. Wynne’s and my own modest piece on the propagandist nature of abnormal psychology textbooks, the intellectual demands of the conference title went largely unnoticed. However fine the presentations they still hewed close to the ICSPP’s favorite themes: the activities of the greedy drug companies (they are!), how important it is to expose their deceits (it is!), how serious mental disturbances are mainly the product of psychosocial injustices and how psychosocial forms of intervention are superior to those based in medicine. The conference did not deal with the idea that if it is delusional to call what the suffering of those we seek to understand and help illnesses and disorders, and if Szasz is correct that all of our terms for these problems are naught but moral judgments, then we are intellectually and ethically bound to replace all of the medical language that so infuses and controls our work. If Szasz is correct, and many ICSPP members implicitly accept that he is, then it is high time to expunge from our thinking the idea that delusions and hallucinations are “symptoms” to be “diagnosed” and “treated.” Perhaps it is time to discuss ways of removing our profession from its dependence on medical insurance and other third party medical payment systems.

Perhaps it is time to take seriously the idea expressed by many in the conference that what we call symptoms are the activities of desperate individual dealing with what is for them unbearable emotional pain in the only manner in which they know how under the physical and social circumstances that comprise their lives. If this is so then might we begin to recognize and express that our work is more in the nature of education than it is any form of treatment. Perhaps it is time as well to begin exploring new theoretical lines of thinking that include the fact that while no single pattern of human behavior (either those we judge to be moral or abnormal) can be explained genetically or by reducing the activities of people to the actions of the molecules in their brains, no human being will ever be understood without recognizing that we are biological beings who each carry within us an individualized version of the evolutionary history of our species and are born temperamentally very different, one from another. What is a “trauma” (how overdue are we to get rid ourselves of that word) to one infant is pleasant stimulation or moderate challenge to another. We are embodied creatures who have souls (whether soul is taken literally or metaphorically) and therefore cannot be reduced to psychosocial forces anymore than to our chemical substrates.

Enough! I enjoyed being with so many of my friends and colleagues at the 2005 conference and look forward to more of the same at future extravaganzas!!!

 

The ICSPP 2005 Conference Tribute to Kevin McCready

By Al Galves

                Saturday night’s banquet at the 2005 Annual Conference was a tribute to Kevin McCready, a celebration of his life and his contribution to ICSPP.

And a tribute it was.  Complete with slides of Kevin talking, laughing, commiserating, cavorting, singing, goofing.  A videotape with clips of his speeches was playing.  Rita DiCarlo sang the Ave Maria, one of his favorites.

Most of all, there were tributes:

To the fun that he brought to relationships.

To his brilliance – who else would sprinkle his talks with quotes from Yeats, Blake, Merton, St. Thomas Aquinas?

To that shy, little boy part of him that he allowed to shine through.

To his commitment to helping seriously mentally ill people in ways that affirmed them and honored their humanity.

To his willingness to take risks – personal, financial, professional - in order to make that commitment real.

To his wit – you had to be listening very carefully or you might miss a gem and you had to have some armor up because it might be aimed at you in a gentle way.

To his willingness to share his knowledge and skill and help others learn to do what he could do and to find their own way to do other and more.

To his humanness – more than one speaker talked of seeing his faults and weakness – and being all the more impressed.

To his love of family – of origin, nuclear and human.

 

            There were tears, perhaps more than would have been expected.  Why was that?  Perhaps because he really was precious in a special way.  One of a kind for sure.  And willing to be who he was even if it might put some people off or lead people to wonder about him.   And, most of all, because he gave himself to the welfare of his fellow humans with abandon.

 

            The speakers included:

 

§         Dr. Dominick Riccio, ICSPP Executive Director

§         Dr. Peter Breggin, ICSPP Founder

§         Dr. Toby Tyler Watson, who was trained by Kevin and owns and operates a clinic in Sheboygan, Wisconsin based partly on Kevin’s model

§         Drs. Pepe Santana and Brent Olsen who were trained by Kevin and carry on his clinic in Fresno, California

§         Dr. Diane Kern, who was partnering with Kevin in establishing additional clinics and who owns and operates clinics in Walnut Creek and San Francisco, California

§         Dr. William Rhoat who was trained by Kevin and works at a clinic based on Kevin’s work in San Francisco

§         Jack McCready, Kevin’s brother

 

            Several others spoke during the open mic following the scheduled speakers.  Kevin’s wife and children and other members of his family attended the banquet.  ICSPP members contributed about $5,000 to the Kevin McCready Research Scholarship which was created by Toby Tyler Watson and about $2,500 to the McCready family.

 

 The Final Question

By Andrew Crosby

During the closing minutes of our latest conference, a participant asked the panel of plenary speakers an intriguing question.  The answers from the panel vexed me.  Others in the audience chimed in but did little to clear my fog.  I couldn’t put my finger on it, but I sensed we had missed a basic point.  Not by much, but we’d missed it.  I also knew that I’d been challenged with the same question and had a definitive response.  Unfortunately, I couldn’t put my finger on that either.  It occurred to me that after three solid days at the conference, I was more tired than I thought.

            I mulled over my confusion as the conference wrapped up and I gathered my things. I’m a slow processor. I’ve refined mulling to an art. I might write a book on it.    The questioner joined me and several others for lunch at the hotel before we said our good-byes. At one point I tried to offer my thoughts on his remarks, but I stumbled, still lacking focus. All I really cared about was my cheeseburger. Once fed and back home, I mulled some more that night and the next morning. I smiled when it became clear. I was right. The answer was simple, right in front of my face.

The question was essentially this: As we struggle against biopsychiatric theories, what does ICSPP have to offer in their place? It seemed to the questioner that ICSPP was advocating getting rid of one model without offering a viable alternative. 

This is a common concern. The question of biopsychiatry’s replacement has visited previous conferences and other discussions. Of the many answers, few spring to mind.  Somewhere, though, I learned a great one. It may have been from an early conference or something I read. I have no specific memory, no quote, no one to credit.  It’s likely an amalgam of elements from many sources absorbed over time. I suspect mulling is involved.

The panel members’ responses were better than I could have come up with at the time, but compared to the answer I picked up some time ago they missed the forest for the trees.  Even brilliant panel members are vulnerable to conference fatigue, perhaps. I needed rest before I could recall my thoughts. Interestingly, I also recalled when a friend challenged me with the same query and I smacked it out of the ball park. It’s a good story. I’ll let you in on it soon.

First, I’ll not tease you. For any of us who may be wondering what we will create to offer as a replacement for biopsychiatry, I will tell you my answer; the gem I scooped up who knows where.  It is this: Nothing.

Yes. Nothing. If anyone is concerned that we are charged with finding something new and sensational to replace biopsychiatry I suggest that on the macro level this is a non-issue. There is no need to find or create biopsychiatry’s replacement. No need, even,  for us to reach consensus on what form an alternative should take. How can this be true?  Because what is needed already exists.

It is us. You and me. It is the psychoanalysts in ICSPP. It is the cognitive therapists among us. It is the behaviorists and humanists. It is the teachers and parent coaches. It is the child study team members, the survivors, and their family members. It is the nurses and the school psychologists, the psychiatrists and the prison therapists. It is everybody I haven’t mentioned but who also belongs to ICSPP because of the values we share. It is also our colleagues, friends, family members, and acquaintances who also engage in caring relationships with people but who are unaware of ICSPP and our ideals.

I don’t see biopsychiatry as a treatment that needs to be replaced with another treatment. It has evolved beyond that. It is a belief system, a strong one. Almost as strong as the one from hundreds of years ago - the one that informed us the Earth was flat.  People just knew it. There was no need for debate. 

Put simply, the belief system is that those of us who are diagnosed with disorders have chemical imbalances or brain diseases. The treatment is psychiatric drugs. Yet those of us who help in ways that respect human dignity are in close contact with diagnosed individuals and other professionals all the time. We are all over the map. We are in the same schools, hospitals, agencies, homes, communities … you name it.

True, we are often in subordinate roles. Our “supportive” efforts are seen as secondary to the “real” treatment, drugs. But we are there. We are in place and we are doing our work, engaging in our various ways be it school counseling, peer support, parent coaching, case work, therapy of any school, presenting to interested community groups, and everything else we do. This means that the “treatment” alternative to biopsychiatry already exists. We are the alternative.

What’s more, we are united in a unique way, not by a single approach but by principals.  We relate with those we help so as to convey the message, Your brain is as good as mine.  As is your heart, your mind, and your soul.

To me, the walls we come up against pertain less to oppressive treatment than to the beliefs that fuel them. As the biopsychiatric belief system wanes, so will the corresponding treatments. Framed that way, our task is to roll back the prevailing beliefs so that we can work more effectively, without having to swim against the tide.

I know. That still sounds bleak. I have no pithy answer to slam that one out of the park. Many believe that therapeutic programs comparable to Soteria House and the San Joaquin Psychotherapy Center are needed. Count me among them. I believe these should, and will, exist. I also believe, however, that while such programs will be a factor in biopsychiatry’s waning influence, they will not be the sole force. Change will come slowly indeed if we do nothing but wait for these programs to emerge and alter things for us.

So, what can we do? Influence people. Some time ago I sought appropriate times to speak with co-workers, and others, about our views. This was tricky. One must creatively work it into discussions, avoid preaching, and all that. It takes practice. Most people were uninterested, but a few were intrigued. I eventually tired and gave up.  

I’ve realized, however, that I made a dent. I’ve also realized I need to renew my efforts. I’m already mulling over some new approaches, improvements on my earlier attempts. These involve impressing people with how effective work can be without pursuing or relying on drugs. The better I’ve become at describing my work and my thinking, the more people ask questions like the one that inspired this article. The more people ask, the more I think, read, and come up with answers that keep people engaged. 

Thus we come to my story. It’s true, this really happened. I offer it to illustrate how I have handled the dilemma our questioner above anticipated; the one where you talk to someone about the fallacies of psychiatric drugs and they ask, “Yeah?  Well, if you don’t use drugs, what’s the alternative?”

            A few years ago I worked at a newly formed case management agency. I was finishing up graduate school and most of the staff were at similar points in their educations and careers. It had become a running gag that I was into doofy things, like theories and concepts. Like many of my co-workers, I was working part-time at an out-patient psychotherapy clinic. I had no problem being into theories and concepts. I liked it, doofy or not.

            One day I’m sitting at my desk, minding my own business, probably thinking brilliant thoughts about some theory or concept. My friend Mack runs up with wide eyes and a toothy grin. He points a finger at me pistol fashion.

            “Dog,” he announces. Officially, I am ‘Big Dog,’ but Mack abbreviates. “I just read the greatest book.”

            “Don’t tease me.”

            “You gotta read it. I know what you’re gonna think, but hear me out. You’ve got to read this one.”

            Mack tells me he’s been trying some of this reading and theory stuff like me.  He’s amped up.  I’m happy for him.

            “You start talking theory around here, they’ll crucify you,” I warn him.

            Mack is unfazed. He wants me to read this book and give it a chance. I tell him I’ll consider it and ask what it is. He darts into his cubicle and returns holding out a Phil McGraw book, Life Strategies.  He reads my face.

            “I know what you’re thinking, Dog.  I know it’s not Sigmund Freud or Gertrude Mahler.”

            “Margaret Mahler.” I take the book from him.

            “Just give it a chance. Promise me you’ll read at least some of it.”

            I propose a deal. I’ll read one Dr. Phil if Mack reads one Peter Breggin. I have discussed my views with Mack. He is sympathetic if not swayed. He agrees to my terms and suggests we read the books, then meet over lunch to discuss, debate, ask questions, whatever.  I love the idea.

            I give him Talking Back to Prozac. It’s more focused than Toxic Psychiatry or Talking Back to Ritalin which I fear will intimidate Little Dog. Two weeks later, we meet at a diner. I am sipping coffee when Mack comes in. He’s talking before he slides into the booth.

            “Listen,” he says. “Here’s what I’d like to do, if it’s O.K. with you.”

            Mack says he has so many questions about Breggin’s book, and related matters, that he wants to forgo discussion of Dr. Phil and just ask about the anti-drug stuff.  I don’t fight him..

            What follows is more interview than discussion. Mack fires off questions, good ones, over his grilled chicken sandwich. I struggle, but do well. Mack is skeptical, but taking it all in. Finally, he takes a breath.

            “O.K.,” he says. “Listen. I get what you’re saying. I can buy that there are all kinds of risks and the science is far less than superb. But … if you do away with the drugs, what do you replace them with?”

            I have to think about that. I know it was in the book, but I’m coming up blank.

            “Well …,” I start. “What do you think we replace them with?” I’m stalling. I act like the answer is so easy Mack should see it any second. I’m hoping I will. Mack talks some more.  I have no idea what he’s saying.  Then, it hits me.  It’s right in front of my face. Something I read or picked up at a conference.

            “So,” Mack says again. “I don’t get it.  If you don’t use medications, what’s the alternative?” 

            “Nothing.”

            Mack scrunches up his face. I let a few seconds go, then continue. “You don’t replace drugs with anything. There’s no need to replace them.” Mack is lost.

            “Think about the kids we work with,” I tell him. “Think about the kids you work with.Who’s involved with them? What goes on?”

            I tell him the kids we help have school counselors, therapists, mentors, and the staff at an employment program many of the agency’s kids attend. They have parents and grandparents, brothers and sisters. 

            “And they’ve got you,” I add. “You and me. We’re case managers, Mack. Our work is to engage with the kid, the family, and everybody involved with them. We get people talking and keep them talking. We get everybody to help with any problem any time it comes up. You give any kid, any family, that kind of attention, and do it well,  and you know what happens?”

            “What?”

            “They get better.”

            “But what about …”

            “The chemical imbalance?”

            “Yeah.”          

            “What chemical imbalance?” Again, I let a few seconds go. “Get it? There’s no reason to replace the drugs.”

            I return to my turkey club. Mack’s face tells the story. He’s mulling it over.

  

 In cleaning out a file cabinet I came across this

anonymous poem about a poor person who needs to seek out a clinic for help.

Thought you might find it interesting.

 

Lloyd Ross

 

                                              INTAKE, INTOOK, TAKEN IN

 

                                                          When I came to see if

                                                someone could see if

                                                I could listen to myself, or if

                                                I listened too loudly

                                                Already--

 

                                                         I was greeted by papers

                                               and forms

                                               and questionnaires

                                               that probed and picked

                                               without reflecting or supporting

                                               or even being warm.

 

                                                         I talked with someone

                                              who wanted me to tell

                                              what I would tell without

                                              all I could tell,

                                              because he had to assign

                                              me to someone else--

                                              I can’t remember his name now.

 

                                                        I was left

                                             having to wait until

                                             whoever I was assigned to

                                             would assign himself

                                             to me--

                                             I resigned myself to that.

 

                                                      And now my crisis

                                            has passed, and I still have to wait

                                            for a phone call

                                            from my assigned someone

                                            to tell him

                                            it’s too late

                                            to need him now…….

 

Schizophrenia Treatment in 7 Easy Steps

 

Adapted from the Michigan Implementation of Medication Algorithms

Physician Procedural Manual, Appendix I: Guidelines for Treating Schizophrenia

 

Excerpted, abridged, and translated into plain English

by Ben Hansen, MindFreedom Michigan

 

If you’re a doctor treating a patient for schizophrenia, the Physician Procedural Manual will help guide your clinical practice and make things a lot easier for you.

At each step of the way, always remember your three options: continue the present drug regimen, adjust the drug dose, or move on to another drug.  Don’t even THINK about taking your patient off drugs.  The manual plainly states, “The schizophrenia algorithm contains no guidelines for antipsychotic medication discontinuation, which is anticipated to be a rare event in the typical mental health clinic patient population.” 

Your main task as a physician is to prescribe drugs. As a rule of thumb, it’s always best to prescribe a new drug before its patent expires.  For this reason, the new drugs called atypical antipsychotics are an excellent choice as first-line treatment. 

Atypical antipsychotics cost twenty times more than older drugs, but cost is only one factor to consider when making a clinical judgement.  Another factor is profit.  With this in mind, schizophrenia can be treated in seven distinct stages, outlined below.

STAGE 1.  Prescribe an atypical antipsychotic such as Zyprexa, Risperdal, or Seroquel.  Some physicians will select a drug based on whichever sales rep last visited the office, but this is not recommended.   Whatever brand you choose, if your patient shows little or no improvement after 4 weeks, go to the next stage.

STAGE 2.  Switch to a different atypical antipsychotic. You may select a particular drug based on the quality of free ballpoint pens provided by the manufacturer, but this is not recommended.  If results are unsatisfactory after a few weeks, go to the next stage.

STAGE 3.  Switch to yet another atypical antipsychotic , or try a conventional antipsychotic such as Haldol for old times’ sake.  If progress remains unsatisfactory after a few more weeks, go to the next stage.

STAGE 4.  Prescribe Clozaril.  Since there’s a 50-50 chance the patient will respond unfavorably to Clozaril, you may skip this stage and go directly to the next stage.

STAGE 5.  Prescribe Clozaril in combination with another antipsychotic, or Clozaril in combination with electroshock.   The manual says, “Almost all studies have shown beneficial effects of electroschock for persistent psychotic states.”  The manual also says, “There are no controlled studies of electroshock for schizophrenia in which number of treatments, duration of treatments, and electrode placement have been systematically evaluated.”  Therefore, if you’re going to use electroshock on the patient, be sure to use it at least ten times, on both sides of the brain.  If this proves unsuccessful, go to the next stage.

STAGE 6.  Try one of the few remaining atypical antipsychotics you haven’t tried yet.  If results are satisfactory, that would be nice but it’s not very likely at this stage, so go to the next stage.

STAGE 7.  Prescribe any combination of two antipsychotics OR two antipsychotics plus electroshock OR two antipsychotics plus a mood stabilizer such as Depakote.  Maintain this regimen for at least 12 weeks, if your patient lives that long.
 

Helpful hints for the clinician

 
In addition to prescribing drugs for schizophrenia, you may need to prescribe drugs for various “co-existing symptoms” of schizophrenia, such as sedatives for agitation, mood stabilizers for hostility, hypnotics for insomnia, antidepressants for depression, and so on. 

 You may also need to prescribe drugs to treat adverse side effects of drugs prescribed for schizophrenia, such as diabetes caused by Zyprexa or tremors caused by Risperdal, not to mention side effects of drugs prescribed for co-existing symptoms, such as hostility caused by antidepressants prescribed for depression and/or depression caused by mood stabilizers prescribed for hostility, and so on.

Before long, you’ll be prescribing drugs to manage side effects of drugs prescribed to manage side effects, like a dog chasing its tail.  The manual explains, “Using a medication to treat a side effect can result in additional adverse effects.”  This is why “side effects algorithms” are included in the manual as well.  Don’t worry.  Just follow the manual.

Always remember to monitor your patient’s progress.  This is a routine task which may be performed in 5 minutes or less during regular office visits.  Use the 8-point rating scale summarized below.
 

1.  Does patient believe others have acted maliciously or with discriminatory intent?
 

2.  Has patient had odd, strange or bizarre thoughts in the past 7 days?
 

3.  Has patient had visions or seen things others cannot see?
 

4.  Is patient’s speech confused, vague, or disorganized?
 

5.  When asked a question, does patient pause for long periods before answering?
 

6.  Does patient’s face remain blank or expressionless?  (“Disregard changes in facial expression due to abnormal involuntary movements, such as tics and tardive dyskinesia,” the manual advises.)
 

7.  Does patient seem withdrawn or unsociable?
 

8.  Does patient dress sloppily, or come to your office with poorly groomed hair?  (“Do not rate grooming as poor if it is simply done in what one might consider poor taste,” the manual advises.)

 
If the answer to all eight questions is no, your patient is probably not taking medications as prescribed.  When noncompliance is a problem, the patient should be restrained if necessary and forcibly injected with a timed release antipsychotic.  Maintain this regimen until patient gains insight into the need for treatment.

 
The cutting edge of science

 
This project was modeled after the Texas Implementation of Medication Algorithms.  A distinguished panel of 25 Michigan experts very carefully replaced the word “Texas” with the word “Michigan” in all appropriate spots.

 
As new studies financed by drug companies discover ways to expand the market, and new products developed by drug companies enter the market, "this algorithm will be periodically revised and updated."  

 
Funding for the Michigan Implementation of Medication Algorithms was provided by the Ethel and James Flinn Foundation of Detroit.  The Michigan Pharmacy Quality Improvement Project, promoting the same agenda and with several of the same committee members, is funded by Eli Lilly, maker of Zyprexa.  Lilly sales representatives carry a wide variety of ballpoint pens and other cool stuff.

 
If you think this is a joke, look at the original document:

 

*******

Ben Hansen is an anti-psychiatry activist who lives in Traverse City, Michigan.

His email address is heartofbear@hotmail.com

 

 SOON AVAILABLE: THE DVD’S FOR THE 2005 ICSPP CONFERENCE: $200.00; $250.00 OVERSEAS  

 

 

Now Available on DVD

15% off for ICSPP Members

 

  The 2003 Seminar Conference

 

TREATING THE DIFFICULT CHILD: ADHD, BIPOLAR AND OTHER DIAGNOSES: CHALLENGING THE

STATUS QUO WIYH SOLUTION BASED THERAPY

 

Peter Breggin, M.D.

“The Biological Basis of Childhood

Disorders:The Scientific Facts”

 

David Cohen, Ph.D.

“New Research on the ADHD Drugs:

A Comparative Study of Stimulants”

 

Brian Kean, M.A.

“The Dangers of Diagnosing Children:

Results of the Multi-modal Treatment Approach Study”

 

Robert Foltz, Ph.D.

“Bipolar, ADHD and Conduct Disorder:

The Diagnostic Dilemma.”

 

Bruce Levine, Ph.D.

“Common-Sense Solutions for Disruptive

Children Without Drugs or Behavioral Manipulation.”

 

Dominick Riccio, Ph.D.

“Family Therapy: the Treatment of Choice

for Working with Difficult Children.”

 

Kevin McCready, Ph.D.

Psychodynamic Therapy with Children and Families

 

David Stein, Ph.D.

“A Drug-Free Practical Program for Children Diagnosed with ADHD and Most Other Behavioral Disorders.”

 

 

 $100.00 for the Complete Set

 

 

2004 CONFERENCE

 

CRITIQUING DISEASE MODELS OF PSYCHOSOCIAL DISTRESS AND IMPLEMENTING PSYCHOSOCIAL THEORIES AND INTERVENTIONS

 

Vera Sharav

Screening for mental illness: The merger of eugenics and the drug industry.

 

David Healy, M.D.

Manufacturing consensus in psychopharmocology: the end of psychiatry as a  Science?

 

Peter R. Breggin, M.D. ,

Violence induced by psychiatric medications: cases, questions and contradictions

 

Brian Kean, Ph.D.

The Risk Society and Attention Deficit Hyperactivity Disorder (ADHD):A Critical Social Research Analysis Concerning the Development and Social  Impact of the ADHD Diagnosis

 

Pam Otis, M.D.

A Pediatric practice using no labels, no psychotropic drugs, and teaching peers

and residents to treat difficult children by asking how and why.

 

Toby Tyler Watson, Psy.D.

The four false pillars of biopsychiatry: examining the scientific facts about the underlying assumptions of biopsychiatry, i.e. chemical imbalances, inheritance, genetics, and adoption studies.

 

Laurence Simon, Ph.D.

Therapy as civics; the patient and therapist as citizens

 

David B. Stein, Ph.D.

Parenting and treating difficult teens without drugs or make believe disease.

 

Dominick Riccio, Ph.D.

The role and therapeutic function of the father in the treatment of difficult and acting out children

 

Matt Irwin, M.D.

Treatment and reversal of schizophrenia without neuroleptics.

 

GEORGE W. ALBEE, Ph.D.

A Radical View of the Causes, Prevention, and treatment  of   Mental Disorders

 

NADINE LAMBERT, PH.D.

The contribution of childhood ADHD, psychostimulant

exposure and problem behavior to adolescent and adult substance abuse

 

CELIA Brown

David oaks

The continuum of support: Real alternatives and self-help approaches

 

Robert Whitaker

Anatomy of an Epidemic: the astonishing rise of mental illness in America

 

James B. Gottstein, J.D.

Psych Rights Legal Campaign Against Forced Drugging and How You Can Participate

 

Raymond DiGiuseppe, Ph.D.

Is anger adequately represented in the DSM?

 

$200.00 for the Complete Set

2000 CONFERENCE

 

PSYCHOSOCIAL SOLUTIONS VS PSYCHIATRIC DRUGS:

THE ETHICS AND EFFICACY OF TREATING CHILDREN AND ADULTS WITH BRAIN DISABLING DRUGS WHEN SCIENCE INDICATES THAT PSYCHOSOCIAL APPROACHES ARE MORE EFFECTIVE AND NON-TOXIC

   Your Psychiatric Drug May Be Your Problem

                                                  Presenters:      Peter R. Breggin, MD  (Chair)

                                                                           David Cohen, Ph.D.

Psychiatry, Malpractice, & Product Liability Issues

                                                   Presenters:    Peter R. Breggin. MD   (Chair)

                                                                           Pam Clay, JD. 

                                                                           Michael Mosher, JD

 

 The Treatment of Deeply Disturbed Children & Adults Without Resort to    

                                                                       Psychiatric Drugs

                                                   Presenters:     Peter R. Breggin, MD   

                                                                           Kevin McCready, Ph.D

                                                                           Tony Stanton, MD

Children In Distress: ADHD & Other Diagnoses

                                                     Presenters:           Peter Breggin, MD

                                                                                   Ron Hopson, Ph.D.

 

Working With Very Disturbed & Traumatized Children

                                                     Presenter:            Tony Stanton, M.D.

 

 

What Is Wrong With Psychiatric Diagnoses: Biopsychiatry & The DSM

                                                Presenter:              Paula Caplan, Ph.D.

 

Drugs In Psychiatry As A Socio-Cultural Phenomenon

                                                     Presenter:              David Cohen, Ph.D 

 

Why We Shouldn’t Label Our Children ADHD or Learning Disabled                                                                          

                                                     Presenters:             Gerald Coles, Ph.D.

                                                                                      David Keirsey, Ph.D.

 

 

Psychotherapy Vs. Drug Therapy With Children

                                                      Presenter:             William Glasser, MD

 

New Legislation, Children, and Medication Abuses

                                                       Presenter:             Hon.. Marion Crecco

 

And They Call It Help:  How Psychiatry Has Failed Our Children

                                                       Presenter:             Louise Armstrong, Ph.D.

Reclaiming Our Children

                                                       Presenters:            Peter R. Breggin, MD

                                                                                       Jake Johnson,Ed.D.

 

 

 

            $100.00 for the Complete Set

 

ICSPP DVD Order Form

DVDs sold only in complete sets

Send order form with check or credit card information to:

ICSPP Conference DVD

Dominick Riccio, Ph.D.

1036 Park Avenue, Suite 1B

New York, NY 10028

 

Name:_____________________________________________________

Address:_____________________________________________________

City:______________________________State:__________Zip:________

Telephone:___________________________________________________

Credit card: Visa___ Mastercard___American Express___Discover____

 

Credit card #______________________________________________

Expiration date: MM/YY____/____

ORDER:

Quantity______2004 Conference x $200.00 = ___________

Quantity______2003 Conference x $100.00 = ___________

Quantity______2000 Conference x $100.00 = ___________

                                                          Total   = ___________

Less 15% ICSPP paid member discount     = -___________

Add $10.00 shipping and handling or

$50.00 for non U.S.A. orders                      = +___________                                                                  Final total due        = ____________

 

 

 

OVER THREE DECADES OF ICSPP ACCOMPLISHMENTS

Stopping the worldwide resurgence of lobotomy and psychosurgery on adults and children, and all psychosurgery in federal and state institutions.

·         The creation of a federal Psychosurgery Commission by Congress (1970's)

·         Alerting professionals to the dangers of tardive dyskinesia in children (1983). Tardive dyskinesia is a potentially devastating neurological disorder caused by neuroleptic or antipsychotic drugs.

·         Alerting professionals to the dangers of dementia produced by long-term neuroleptic drug use (1983).

·         Motivating the FDA to force the drug companies to put a new class warning of tardive dyskinesia on their labels for neuroleptic drugs (1985).

·         The withdrawal of a large multi-agency federal program to perform dangerous invasive experiments in inner-city kids in search of supposed genetic and biochemical causes of violence (the violence initiative) (early 1990's).

·         The initial cancellation and later modification of a potentially racist federally sponsored conference on the genetics of violence (early 1990's).

·         Alerting the profession to danger of down-regulation and dangerous withdrawal reactions from the new SSRI antidepressants such as Prozac, Zoloft, and Paxil (1992-4).

·         Monitoring, and at times modifying or stopping unethical, hazardous experimental research on children (1973-present).

·         Encouraging that NIH Consensus Development Conference on Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder to raise serious concerns about "ADHD" and stimulants for children.

While each of these critiques and reform projects was initially considered highly controversial, and while each was frequently opposed by organized psychiatry, most are now widely accepted as rational, ethical, and scientific. For example,

Psychosurgery is no longer widely practiced and not at all in state or federal institutions or on children in the United States; the multi-agency federal program aimed at using invasive biological procedures on inner-city children has been disbanded; the conference on the genetics of violence was delayed and then vastly modified; all experts now recognize the dangers of tardive dyskinesia in children; many researchers have confirmed that the neuroleptic drugs produce dementia, and experienced doctors now recognize the potential for dangerous withdrawal effects from the SSRIs.

      Become a member by mailing a $25 check or money order (U.S. funds) ($35 U.S. dollars if mailing address is international). Check or money order should be made out to ICSPP. An additional tax-deductible donation can be added, and would be deeply appreciated.

 

 

 
Your Donations to ICSPP help!

            Your membership in ICSPP covers the expense of producing four newsletters per annum and other mailings, and helps us to continue to respond to the hundreds of information queries we receive from the public, the media, and concerned professionals.

ICSPP edits Ethical Human Psychology and Psychiatry published by Springer Publishing. A subscription to EHPP is $52.00 and can be ordered by clicking on “Journal” on our website (www.icspp.org). However, if you subscribe simultaneously with your dues payment the total of dues and subscription is $100.00 ($120.00 outside of the USA), a savings of $12.00. EHPP is vital both to those who seek to read, write, and publish on issues critical to institutional psychiatry as well as to the life of ICSPP as a scientific and educational institution. If paying by check please indicate that your payment is for both dues and subscription as well as any donation you care to make. Thank you.

            General members receive the newsletter and the satisfaction of supporting mental health reform efforts for children, elders, racial and ethnic minorities, and other vulnerable populations. Members also receive a discount on the journal, Ethical Human Sciences and Services.

            We are a volunteer organization with no officers receiving salaries or other financial benefits. ICSPP is a nonprofit 501 C3 organization.

 

 

International Center for the Study of Psychiatry and Psychology

1036 Park Avenue, Suite 1B

New York NY 10028

Telephone: (212) 861-7400

 

Join US. Become a member of ICSPP today! 2006 dues are due NOW!

Name___________________________________________________________________

 

Title_________________Organization_______________________________________

 

Address________________________________________________________________

 

Address________________________________________________________________

 

City______________ State___________________________ Zip Code_____________

 

Country___________________________ E-mail_______________________________

 

Telephone_______________________________________________________________

 

Mail form and check to

Robert Sliclen,

450 Washington Ave.

TWP of Washington,

New Jersey, 07676-4031

 

 

 

ICSPP Offices and Directors around the U.S. and the World

 


International Executive Director

Dominick Riccio, Ph.D.

1036 Park Avenue, Suite 1B

New York, NY 10028

(212) 861-7400

 

International & North American Offices

Peter R. Breggin, MD. Founder and

Director Emeritus.

 

Intl. Executive Director Emeritus, Advisory Council Member Ginger Ross Breggin

The Breggin’s address:

101 East State Street, PBM 112

Ithaca, NY 14850-5543

(607) 272-5328

 

United States regional Director

Lloyd Ross, Ph.D.
27 North Broad Street
Ridgewood, New Jersey 07450
Phone: (201) 445-0280
Email: Lloydross1@worldnet.att.net

 

Newsletter Editor

Laurence Simon, Ph.D.
2717 Belle Road.
Bellmore, NY 11710
516-826-8860
lrsimon@optonline.net

 

Director of Communications

Andrew Levine, LCSW
267 N. Central Park Avenue
White Plains, NY 10606
(914) 633- 1905

 

Director of Membership Services

Robert Sliclen, Ph.D.
450 Washington Avenue
Twp of Washington, NJ 07676-4031
(201) 664-2566

Editors - Ethical Human Psychology and Psychiatry: An International Journal of Critical Inquiry

Jonathan Leo, Ph.D.
Laurence Simon, Ph.D.

For International/National membership, newsletter, advocacy, and technical information contact the international office. For regional activities contact the regional directors

 

CSPP Australia

Brian Keen, M.A.

Lecturer in Education

Southern Cross University

PO Box 157, Lismore, NSW, 2480

Australia

Phone: (066) 203797

 

CSPP Belgium

Philip Hennaux, M.D.

Medical Director, La Piece

71 Rue Hotel Des Monnaies

1060 Bruxelles, Belgium

Phone: 2-646-96-01

 

CSPP Switzerland

Piet Westdijk, Dr.Med. [M.D.]

FMH Psychiatry and Psychotherapy

FMH Child Psychiatry & Child Psychotherapy

Sattelgasse 4, CH_4051 Basel, SwitzerlandPhone: (41) 61 262 22222

 

CSPP South America

Alberto Ferguson, M.D.

Av. 82, No. 9-86, Apt. 402

Bogota, Columbia, SA.

(011) (571) 636-9050

US address:

4405 N. W. 73 Avenue, Ste.051-5106

Miami, Fla. 33166-6400

 

 

CSPP-Southeast

Barry Duncan

8611 Banyan Court,

Tamarac, Fl. 33321

(954) 721-2981

 

USA-CSPP Four Corners

Louis Wynne, Ph.D.

1420 Carlisle NE, Suite 102

Albuquerque, NM 87110

(505) 280-4400

 

USA-Great Lakes

Robert Foltz, Psy.D.

100 S. Atkinson, Suite 203

Grayslake, Il. 60030

(847) 518-9546

DrRobertF981@aol.com

 

 

USA-CSPP Mid-Atlantic

David Stein, Ph.D.

Longwood College, Psychology Dept

Farmville, VA 23909

(804) 395-2322

 

 USA-CSPP New England

Emmy Rainwalker

187 Merriam Hill Road

Greenville, NH 03048

(603) 878-3362

emmy@emmyrainwalker.com

 

 

USA-CSPP Northern California

Diane Kern, Dr. Criminology, MFT

Insight Center

1372 North Main Street, #207

Walnut Creek, CA 94596

(925) 943-5503

 

 

Website: www.icspp.org

 


International Center for the Study of Psychiatry and Psychology

1036 Park Avenue, Suite 1B

New York, NY 10028

(212) 861-7400

            About the International Center for the Study of Psychiatry and Psychology. The International Center for the Study of Psychiatry and Psychology (ICSPP) is a nonprofit, 501C research and educational network of professionals and lay persons who are concerned with the impact of mental health theory and practice upon individual’s well-being, personal freedom, families, and communities. For over three decades ICSPP has been informing professionals, the media, and the public about the potential dangers of drugs, electroshock, psychosurgery, and the biological theories of psychiatry ICSPP is supported by donations and contributions. Officers receive no salary or other remuneration. Help us continue our work by sending a donation to ICSPP today.

 

 

 

 
Next >